Shop around or check out the links in Hollys Amazon Shop
Early Clinical Evidence (Small but Promising) A 2025 case series followed five women with lipedema and insulin resistance treated with the GLP-1 medication exenatide (Patton et al., 2025)
Alt Text: Retatrutide peptide mechanism diagram showing GIP, GLP-1, and glucagon receptor pathways Full AI Image Prompt: Create a clean clinical infographic titled Retatrutide Triple-Receptor Mechanism. Show an abstract retatrutide peptide icon in the center with three clearly labeled branches to GIP receptor, GLP-1 receptor, and Glucagon receptor. Under each receptor, include short neutral labels: insulin response research, appetite and glucose signaling, and energy metabolism research. Use a modern medical editorial style, white background, subtle blue and green accents, simple vector icons, no people, no syringes, no product packaging, no before-and-after imagery, and no guaranteed outcome language
The label contraindicates phentermine in people with a history of cardiovascular disease such as coronary artery disease, stroke, arrhythmias, congestive heart failure or uncontrolled hypertension
The process is fully virtual